Employing neutralizing antibodies against E-selectin, ICAM-1 and VCAM-1 revealed that anti-E-selectin was able to block tumor cell binding, while anti-ICAM-1 and anti-VCAM-1 failed to significantly block tumor cell binding (40). The gene discussed is VCAM1; the disease is neoplasm.